Active ingredient
Methotrexate sodium NDC Codes
Methotrexate sodium is an active ingredient in 57 finished products listed with the FDA, under 4 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Methotrexate, Rasuvo, Trexall, Methotrexate Sodium
- Labelers
- Medexus Pharma Inc., Hospira, Inc., Eugia US LLC, Bryant Ranch Prepack, Teva Women's Health LLC, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Teva Parenteral Medicines, Inc., Bryant Ranch Prepack, NuCare Pharmaceuticals, Inc.
- Strengths
- Methotrexate sodium 2.5 mg/1; Methotrexate sodium 25 mg/mL; Methotrexate sodium 50 mg/2mL; Methotrexate sodium 100 mg/4mL; Methotrexate sodium 200 mg/8mL; Methotrexate sodium 250 mg/10mL; Methotrexate sodium 7.5 mg/.15mL; Methotrexate sodium 10 mg/.2mL; Methotrexate sodium 12.5 mg/.25mL; Methotrexate sodium 15 mg/.3mL; Methotrexate sodium 17.5 mg/.35mL; Methotrexate sodium 20 mg/.4mL; Methotrexate sodium 22.5 mg/.45mL; Methotrexate sodium 25 mg/.5mL; Methotrexate sodium 30 mg/.6mL; Methotrexate sodium 5 mg/1; Methotrexate sodium 7.5 mg/1; Methotrexate sodium 10 mg/1; Methotrexate sodium 15 mg/1; Methotrexate sodium 1 g/1
- Dosage forms
- Injection, Solution, Tablet, Tablet, Film coated, Injection, Powder, Lyophilized, For solution
- Routes
- Oral, Subcutaneous, Intramuscular, Intravenous, Intrathecal, Intra-arterial
- Drug classes (FDA established)
- Folate Analog Metabolic Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 104
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Alembic Pharmaceuticals Inc. | 62332-711 | 62332-0711-05 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Alembic Pharmaceuticals Inc. | 62332-712 | 62332-0712-01 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Alembic Pharmaceuticals Limited | 46708-711 | 46708-0711-05 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Alembic Pharmaceuticals Limited | 46708-712 | 46708-0712-01 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Safecor Health LLC | 48433-065 | 48433-0065-05 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Coupler LLC | 67046-1524 | 67046-1524-03 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Hospira, Inc. | 61703-161 | 61703-0161-05 | — |
| Methotrexate | Methotrexate sodium 50 mg/2mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Eugia US LLC | 55150-510 | 55150-0510-0155150-0510-05 | — |
| Methotrexate | Methotrexate sodium 100 mg/4mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Eugia US LLC | 55150-511 | 55150-0511-0155150-0511-10 | — |
| Methotrexate | Methotrexate sodium 200 mg/8mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Eugia US LLC | 55150-512 | 55150-0512-0155150-0512-10 | — |
| Methotrexate | Methotrexate sodium 250 mg/10mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Eugia US LLC | 55150-513 | 55150-0513-01 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Alembic Pharmaceuticals Inc. | 62332-730 | 62332-0730-3162332-0730-36 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Alembic Pharmaceuticals Limited | 46708-730 | 46708-0730-3146708-0730-36 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-2647 | 72162-2647-0172162-2647-02 | — |
| Methotrexate Sodium | Methotrexate sodium 2.5 mg/1 | TabletOral | Elite Laboratories, Inc. | 64850-330 | 64850-0330-01 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Hospira, Inc. | 61703-124 | 61703-0124-40 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Proficient Rx LP | 82804-136 | 82804-0136-30 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1772 | 71335-1772-0171335-1772-0271335-1772-03+5 more | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Accord Healthcare Inc. | 16729-486 | 16729-0486-01 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3991 | 68071-3991-09 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Chartwell RX, LLC | 62135-772 | 62135-0772-35 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2221 | 71335-2221-0171335-2221-0271335-2221-03+5 more | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3765 | 68071-3765-0668071-3765-09 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-182 | 59651-0182-0159651-0182-36 | — |
| Methotrexatemethotrexate sodium | Methotrexate sodium 2.5 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-2174 | 72162-2174-01 | — |
| Methotrexatemethotrexate sodium | Methotrexate sodium 2.5 mg/1 | TabletOral | Sun Pharmaceutical Industries, Inc. | 47335-235 | 47335-0235-8347335-0235-96 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | AvKARE | 42291-594 | 42291-0594-01 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Hospira, Inc. | 61703-350 | 61703-0350-10 | — |
| Rasuvomethotrexate | Methotrexate sodium 7.5 mg/.15mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-505 | 59137-0505-0159137-0505-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 10 mg/.2mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-510 | 59137-0510-0159137-0510-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 12.5 mg/.25mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-515 | 59137-0515-0159137-0515-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 15 mg/.3mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-520 | 59137-0520-0159137-0520-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 17.5 mg/.35mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-525 | 59137-0525-0159137-0525-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 20 mg/.4mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-530 | 59137-0530-0159137-0530-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 22.5 mg/.45mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-535 | 59137-0535-0159137-0535-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 25 mg/.5mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-540 | 59137-0540-0159137-0540-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 30 mg/.6mL | Injection, SolutionSubcutaneous | Medexus Pharma Inc. | 59137-550 | 59137-0550-0159137-0550-04 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Hospira, Inc. | 61703-408 | 61703-0408-25 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Teva Parenteral Medicines, Inc. | 0703-3675 | 00703-3675-01 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Teva Parenteral Medicines, Inc. | 0703-3678 | 00703-3678-01 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Teva Parenteral Medicines, Inc. | 0703-3671 | 00703-3671-01 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Hospira, Inc. | 61703-350 | 61703-0350-38 | — |
| Methotrexatemethotrexate sodium | Methotrexate sodium 25 mg/mL | Injection, SolutionIntra-arterial, Intramuscular, Intravenous | Fresenius Kabi USA, LLC | 63323-123 | 63323-0123-10 | — |
| Trexallmethotrexate | Methotrexate sodium 5 mg/1 | Tablet, Film coatedOral | Teva Women's Health LLC | 51285-366 | 51285-0366-01 | — |
| Trexallmethotrexate | Methotrexate sodium 7.5 mg/1 | Tablet, Film coatedOral | Teva Women's Health LLC | 51285-367 | 51285-0367-01 | — |
| Trexallmethotrexate | Methotrexate sodium 10 mg/1 | Tablet, Film coatedOral | Teva Women's Health LLC | 51285-368 | 51285-0368-01 | — |
| Trexallmethotrexate | Methotrexate sodium 15 mg/1 | Tablet, Film coatedOral | Teva Women's Health LLC | 51285-369 | 51285-0369-01 | — |
| Methotrexate | Methotrexate sodium 25 mg/mL | Injection, SolutionIntramuscular, Intrathecal, Intravenous, Subcutaneous | Hospira, Inc. | 61703-408 | 61703-0408-41 | — |
| Methotrexatemethotrexate sodium | Methotrexate sodium 1 g/1 | Injection, Powder, Lyophilized, For solutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Fresenius Kabi USA, LLC | 63323-122 | 63323-0122-50 | — |
| Methotrexate | Methotrexate sodium 2.5 mg/1 | TabletOral | Mylan Institutional Inc. | 51079-670 | 51079-0670-05 | — |
Methotrexate sodium: common questions
- Which drugs contain Methotrexate sodium?
- Methotrexate, Rasuvo, Trexall, Methotrexate Sodium.
- Is there a J-code for Methotrexate sodium?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.